Trade Summary

3 days ago, Janney Daniel, serving as Dir at Krystal Biotech, Inc. (KRYS), sold 60,161 shares at $268.44 per share, for a total transaction value of $16,149,383.00. Following this transaction, Janney Daniel now holds 85,096 shares of KRYS.

This sale represents a 41.00% decrease in Janney Daniel's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 24, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 2 days after the trade was made.

Krystal Biotech, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.